ORIC
Oric Pharmaceuticals Inc
NASDAQ · Biotechnology
$10.42
+0.46 (+4.62%)
Open$10.43
Previous Close$9.96
Day High$10.66
Day Low$9.99
52W High$14.93
52W Low$3.90
Volume—
Avg Volume1.70M
Market Cap1.01B
P/E Ratio—
EPS$-1.73
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+401.5% upside
Current
$10.42
$10.42
Target
$52.26
$52.26
$31.55
$52.26 avg
$71.26
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 151.33M | 156.80M | 123.33M |
| Net Income | -16,895,209 | -20,414,835 | -15,522,009 |
| Profit Margin | -11.2% | -13.0% | -12.6% |
| EBITDA | -22,168,918 | -26,679,727 | -20,408,682 |
| Free Cash Flow | -10,591,679 | -9,966,569 | -9,555,180 |
| Rev Growth | +7.8% | +20.1% | +4.2% |
| Debt/Equity | 0.36 | 0.45 | 0.43 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |